U.S. flag

An official website of the United States government

NM_001101426.4(CRPPA):c.466G>A (p.Asp156Asn) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 7, 2012
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000032811.5

Allele description [Variation Report for NM_001101426.4(CRPPA):c.466G>A (p.Asp156Asn)]

NM_001101426.4(CRPPA):c.466G>A (p.Asp156Asn)

Gene:
CRPPA:CDP-L-ribitol pyrophosphorylase A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p21.2
Genomic location:
Preferred name:
NM_001101426.4(CRPPA):c.466G>A (p.Asp156Asn)
HGVS:
  • NC_000007.14:g.16406129C>T
  • NG_032690.2:g.20194G>A
  • NM_001101417.4:c.466G>A
  • NM_001101426.4:c.466G>AMANE SELECT
  • NM_001368197.1:c.466G>A
  • NP_001094887.1:p.Asp156Asn
  • NP_001094896.1:p.Asp156Asn
  • NP_001355126.1:p.Asp156Asn
  • A4D126:p.Asp156Asn
  • NC_000007.13:g.16445754C>T
  • NR_160656.1:n.682G>A
Protein change:
D156N; ASP156ASN
Links:
UniProtKB: A4D126#VAR_069741; OMIM: 614631.0011; dbSNP: rs397514547
NCBI 1000 Genomes Browser:
rs397514547
Molecular consequence:
  • NM_001101417.4:c.466G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001101426.4:c.466G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001368197.1:c.466G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_160656.1:n.682G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7
Synonyms:
WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, ISPD-RELATED; Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7
Identifiers:
MONDO: MONDO:0013835; MedGen: C3553330; Orphanet: 899; OMIM: 614643

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000056579OMIM
no assertion criteria provided
Pathogenic
(Dec 7, 2012)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly.

Vuillaumier-Barrot S, Bouchet-Séraphin C, Chelbi M, Devisme L, Quentin S, Gazal S, Laquerrière A, Fallet-Bianco C, Loget P, Odent S, Carles D, Bazin A, Aziza J, Clemenson A, Guimiot F, Bonnière M, Monnot S, Bole-Feysot C, Bernard JP, Loeuillet L, Gonzales M, Socha K, et al.

Am J Hum Genet. 2012 Dec 7;91(6):1135-43. doi: 10.1016/j.ajhg.2012.10.009.

PubMed [citation]
PMID:
23217329
PMCID:
PMC3516603

Details of each submission

From OMIM, SCV000056579.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 2 sib fetuses, born of consanguineous parents, with congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A7 (MDDGA7; 614643), Vuillaumier-Barrot et al. (2012) identified a homozygous 466G-A transition in exon 2 of the ISPD gene, resulting in an asp156-to-asn (D156N) substitution at a highly conserved residue. The mutation was not found in several large control databases. The fetuses were ascertained due to severe cobblestone lissencephaly.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 9, 2024